Mesenchy stem cells. Potential use in cell and gene therapy for bone loss caused by ageing and osteoporosis;Mesenkymale stamceller: Potentielle anvendelser i celle-og genterapi ved knogletab forårsaget af aldring og osteoporose

Ugeskrift for Laeger

Volumn 163, Issue 40, 2001, Pages 5491-5495

  Justesen, Jeannette ^b   Stenderup, Karin ^b   Kassem, Moustapha S ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; BONE DEVELOPMENT; BONE MARROW CELL; BONE REMODELING; CELL DIFFERENTIATION; FRACTURE HEALING; GENE THERAPY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL MOBILIZATION;

AGING; ANIMALS; BONE MARROW CELLS; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; FRACTURE HEALING; GENE THERAPY; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; OSTEOGENESIS; OSTEOPOROSIS;

EID: 0035488958     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
2. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996; 11: 312-24.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
4. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-61.
5. Stenderup K, Justesen J, Eriksen EF, Kassem M. Ageing is associated with decreased proliferative potential of human bone marrow osteoprogenitor cells in vitro. Bone 2000; 26: 11S.
6. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84: 4164-73.
7. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-64.
8. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-71.
9. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-34.
10. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339: 953-9.
11. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytos after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96: 10711-6.
12. Kassem MS, Mosekilde L, Eriksen EF. Patofysiologien bag det aldersrelaterede knogletab. Ny indsigt i cellulære og molekyterbiologiske mekanismer. Ugeskr Læger 1999; 161: 5663-6.
13. Stenderup K, Justesen J, Eriksen EF, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 2001; 16: 1120-9.
14. Justesen J, Stenderup K, Ebbesen EN, Mosekilde Li, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is Increased with aging and in patients with osteoporosis. Biogeron 2001; 2: 165-71.
15. Justesen J. Effect of ageing and osteoporosis on adipocyte cell differentiation in human bone marrow. Institut for Molekylær og Strukturel Biologi, Aarhus Universitet 1999; 1-54 (kandidatspeciale).
16. Kassem M, Brixen K, Mosekilde L, Eriksen EF. Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994; 54: 1-6.
17. Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest 1998; 101: 1737-44.
18. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-64.
19. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001; 97: 1227-31.
20. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-13.